SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mercury Laboratories informs about newspaper cuttings

14 Feb 2025 Evaluate

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mercury Laboratories has informed that it attached newspaper cuttings for publication of Unaudited Financial Result for the quarter and nine months ended on December 31, 2024 under Regulation 33 of SEBI (LODR), Regulations, 2015 published in newspapers, Active Times (English) and Mumbai Lakshdeep (Marathi). The said newspaper advertisement provides a Quick Response (QR) Code and the weblink of the Company's website to access complete financial results for the said period.

The above information is a part of company’s filings submitted to BSE.

Mercury Laboratories Share Price

799.00 0.00 (0.00%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×